1. Bendamustine followed by obinutuzumab and venetoclax in chronic lymphocytic leukaemia (CLL2-BAG): primary endpoint analysis of a multicentre, open-label, phase 2 trial. Issue 9 (September 2018) Authors: Cramer, Paula; von Tresckow, Julia; Bahlo, Jasmin; Robrecht, Sandra; Langerbeins, Petra; Al-Sawaf, Othman; Engelke, Anja; Fink, Anna-Maria; Fischer, Kirsten; Tausch, Eugen; Seiler, Till; Fischer von Weikersthal, Ludwig; Hebart, Holger; Kreuzer, Karl-Anton; Böttcher, Sebastian; Ritgen, Matthias; K... Journal: Lancet oncology Issue: Volume 19:Issue 9(2018) Page Start: 1215 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. HOVON110/ReBeL Study: Results of the Phase I Part of a Randomized Phase I/II Study of Lenalidomide, Rituximab With or Without Bendamustine in Patients With Relapsed/Refractory Follicular Lymphoma. Issue 1 (February 2020) Authors: Stevens, Wendy B.C.; Bakunina, Katerina; Cuijpers, Marloes; Chamuleau, Martine; Beeker, Aart; Fijnheer, Rob; Hebart, Holger; Visser, Hein P.J.; Doorduijn, Jeanette K.; Linton, Kim; Dreyling, Martin; de Jong, Daphne; Kersten, Marie José Journal: HemaSphere Issue: Volume 4:Issue 1(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Efficacy and Safety of Tirabrutinib and Idelalisib With or Without Obinutuzumab in Relapsed Chronic Lymphocytic Leukemia. Issue 6 (25th June 2022) Authors: Kutsch, Nadine; Pallasch, Christian; Decker, Thomas; Hebart, Holger; Chow, Kai Uwe; Graeven, Ullrich; Kisro, Jens; Kroeber, Alexander; Tausch, Eugen; Fischer, Kirsten; Fink, Anna-Maria; Wendtner, Clemens-Martin; Ritgen, Matthias; Stilgenbauer, Stephan; Zhang, Danjie; Li, Biao; Jürgensmeier, Julia... Journal: HemaSphere Issue: Volume 6:Issue 6(2022) Page Start: e729 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Preinfection laboratory parameters may predict COVID‐19 severity in tumor patients. (13th June 2021) Authors: Kiani, Alexander; Roesch, Romina; Wendtner, Clemens M.; Kullmann, Frank; Kubin, Thomas; Südhoff, Thomas; Augustin, Marinela; Schaich, Markus; Müller‐Naendrup, Clemens; Illerhaus, Gerald; Hartmann, Frank; Hebart, Holger; Seggewiss‐Bernhardt, Ruth; Bentz, Martin; Späth‐Schwalbe, Ernst; Reimer, Pete... Journal: Cancer medicine Issue: Volume 10:Number 13(2021) Page Start: 4424 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Phase III randomized, double‐blind study of paclitaxel with and without everolimus in patients with advanced gastric or esophagogastric junction carcinoma who have progressed after therapy with a fluoropyrimidine/platinum‐containing regimen (RADPAC). Issue 9 (7th May 2020) Authors: Lorenzen, Sylvie; Knorrenschild, Jorge Riera; Pauligk, Claudia; Hegewisch‐Becker, Susanna; Seraphin, Jörg; Thuss‐Patience, Peter; Kopp, Hans‐Georg; Dechow, Tobias; Vogel, Arndt; Luley, Kim Barbara; Pink, Daniel; Stahl, Michael; Kullmann, Frank; Hebart, Holger; Siveke, Jens; Egger, Matthias; Homan... Journal: International journal of cancer Issue: Volume 147:Issue 9(2020) Page Start: 2493 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Randomized phase 2 study of otlertuzumab and bendamustine versus bendamustine in patients with relapsed chronic lymphocytic leukaemia. (15th December 2016) Authors: Robak, Tadeusz; Hellmann, Andrzej; Kloczko, Janusz; Loscertales, Javier; Lech‐Maranda, Ewa; Pagel, John M.; Mato, Anthony; Byrd, John C.; Awan, Farrukh T.; Hebart, Holger; Garcia‐Marco, Jose A.; Hill, Brian T.; Hallek, Michael; Eisenfeld, Amy J.; Stromatt, Scott C.; Jaeger, Ulrich Journal: British journal of haematology Issue: Volume 176:Number 4(2017) Page Start: 618 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. CNS progression during vinblastine or targeted therapies for high‐risk relapsed ALK‐positive anaplastic large cell lymphoma: A case series. Issue 6 (7th March 2018) Authors: Ruf, Stephanie; Hebart, Holger; Hjalgrim, Lisa Lyngsie; Kabickova, Edita; Lang, Peter; Steinbach, Daniel; Schwabe, Georg C.; Woessmann, Wilhelm Journal: Pediatric blood & cancer Issue: Volume 65:Issue 6(2018) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Phase II study of bortezomib, cyclophosphamide and dexamethasone as induction therapy in multiple myeloma: DSMM XI trial. (29th September 2017) Authors: Einsele, Hermann; Engelhardt, Monika; Tapprich, Christoph; Müller, Jürgen; Liebisch, Peter; Langer, Christian; Kropff, Martin; Mügge, Lars O.; Jung, Wolfram; Wolf, Hans‐Heinrich; Metzner, Bernd; Hart, Christina; Gramatzki, Martin; Hertenstein, Bernd; Pfreundschuh, Michael; Rösler, Wolf; Fischer, ... Journal: British journal of haematology Issue: Volume 179:Number 4(2017) Page Start: 586 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Momelotinib versus danazol in symptomatic patients with anaemia and myelofibrosis (MOMENTUM): results from an international, double-blind, randomised, controlled, phase 3 study. Issue 10373 (28th January 2023) Authors: Verstovsek, Srdan; Gerds, Aaron T; Vannucchi, Alessandro M; Al-Ali, Haifa Kathrin; Lavie, David; Kuykendall, Andrew T; Grosicki, Sebastian; Iurlo, Alessandra; Goh, Yeow Tee; Lazaroiu, Mihaela C; Egyed, Miklos; Fox, Maria Laura; McLornan, Donal; Perkins, Andrew; Yoon, Sung-Soo; Gupta, Vikas; Kilad... Journal: Lancet Issue: Volume 401:Issue 10373(2023) Page Start: 269 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Lenalidomide maintenance after first-line therapy for high-risk chronic lymphocytic leukaemia (CLLM1): final results from a randomised, double-blind, phase 3 study. Issue 10 (October 2017) Authors: Fink, Anna Maria; Bahlo, Jasmin; Robrecht, Sandra; Al-Sawaf, Othman; Aldaoud, Ali; Hebart, Holger; Jentsch-Ullrich, Kathleen; Dörfel, Steffen; Fischer, Kirsten; Wendtner, Clemens-Martin; Nösslinger, Thomas; Ghia, Paolo; Bosch, Francesc; Kater, Arnon P; Döhner, Hartmut; Kneba, Michael; Kreuzer, Ka... Journal: Lancet Issue: Volume 4:Issue 10(2017) Page Start: e475 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗